Clinical experience with venetoclax and hypomethylating agents (HMA) in patients with newly diagnosed and relapsed or refractory KMT2A-Rearranged acute myeloid leukemia (AML)
- 10 September 2022
- journal article
- other
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 63 (13) , 3232-3236
Abstract
Rearrangements of lysine [K] methyltransferase 2 A (KMT2A) gene, previously known as the MLL gene, occur in 3 to 7% of adult patients with de novo AML and are enriched in therapy-related disease, p...Keywords
Funding Information
- the National Institute of Health K12 (5K12CA001727-27)
This publication has 11 references indexed in Scilit:
- Clinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AMLBlood Advances, 2021
- Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/ KMT2AProceedings of the National Academy of Sciences, 2020
- Azacitidine and Venetoclax in Previously Untreated Acute Myeloid LeukemiaNew England Journal of Medicine, 2020
- Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AMLBlood, 2020
- Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panelBlood, 2017
- A panoramic view of acute myeloid leukemiaNature Genetics, 2013
- Prognostic Factors in Adult Patients up to 60 Years Old With Acute Myeloid Leukemia and Translocations of Chromosome Band 11q23: Individual Patient Data–Based Meta-Analysis of the German Acute Myeloid Leukemia IntergroupJournal of Clinical Oncology, 2009
- MLL translocations, histone modifications and leukaemia stem-cell developmentNature Reviews Cancer, 2007
- Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)Blood, 2002
- Adult Patients With De Novo Acute Myeloid Leukemia and t(9; 11)(p22; q23) Have a Superior Outcome to Patients With Other Translocations Involving Band 11q23: A Cancer and Leukemia Group B StudyBlood, 1997